# A Clinical Study of Docetaxel for Injection (Albumin-bound) in Patients With Gastric Cancer

Source: https://onco.cc/trials/nct06296706/  
OnCo record `nct06296706` (Trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

A phase 3 trial of Docetaxel in gastric & gastro-oesophageal junction cancer, run by CSPC ZhongQi Pharmaceutical Technology Co., Ltd., now recruiting.

## Summary

A Clinical Study of Docetaxel for Injection (Albumin-bound) in Patients With Gastric Cancer is a phase 3 interventional study registered as NCT06296706 by CSPC ZhongQi Pharmaceutical Technology Co., Ltd., with 630 participants planned, started 2024-02-27 and due to reach its primary completion in 2026-06-01. Interventions recorded: Docetaxel for injection (Albumin-bound) and Taxotere (docetaxel).

## Fields

- Kind: Trial
- Status: recruiting
- Last checked: 2026-09-16
- Tags: pipeline; ctgov-ingest
- Registry id: NCT06296706
- Phase: 3
- Setting: A Multicenter, Randomized, Controlled Phase III Clinical Study of Docetaxel for Injection (Albumin-bound) Versus Taxotere in Gastric Cancer
- Sponsor: CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
- Enrolled: 630

## Sources

- ClinicalTrials.gov NCT06296706: https://clinicaltrials.gov/study/NCT06296706

## Connected records

- cancers: [Gastric & gastro-oesophageal junction cancer](https://onco.cc/cancers/gastric/)
- drugs: [Docetaxel](https://onco.cc/drugs/docetaxel/)
- companies: [CSPC Pharmaceutical Group](https://onco.cc/companies/cspc/)

---
JSON: https://onco.cc/api/v1/entities/nct06296706.json